Literature DB >> 16840349

The structure of G4, the poxvirus disulfide oxidoreductase essential for virus maturation and infectivity.

Hua-Poo Su1, David Yin-Wei Lin, David N Garboczi.   

Abstract

The possibility of the release of smallpox virus into a predominantly nonimmunized population highlights the importance of understanding poxvirus biology. Poxviruses encode a conserved pathway that is required to oxidize disulfide bonds in nascent viral proteins that fold in the reducing environment of the eukaryotic host cytoplasm. We present the structure of the last enzyme of the vaccinia virus pathway, G4, which is almost identical in smallpox virus. G4 catalyzes the formation of disulfide bonds in proteins that are critical for virus maturation and host cell infection. G4 contains a thioredoxin fold and a Cys-X-X-Cys active site. In solution, G4 monomers and dimers are observed. In the crystal, G4 is found as a dimer that buries 4,500 A(2) in the interface and occludes the active site, which could protect the reactive disulfide from reduction in the cytoplasm. The structure serves as a model for drug design targeting viral disulfide bond formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840349      PMCID: PMC1563705          DOI: 10.1128/JVI.00521-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Complete genomic sequence of the Amsacta moorei entomopoxvirus: analysis and comparison with other poxviruses.

Authors:  A L Bawden; K J Glassberg; J Diggans; R Shaw; W Farmerie; R W Moyer
Journal:  Virology       Date:  2000-08-15       Impact factor: 3.616

2.  Poxvirus multiprotein entry-fusion complex.

Authors:  Tatiana G Senkevich; Suany Ojeda; Alan Townsley; Gretchen E Nelson; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

3.  The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites.

Authors:  Geng Tian; Song Xiang; Robert Noiva; William J Lennarz; Hermann Schindelin
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

4.  Vaccinia virus G4L glutaredoxin is an essential intermediate of a cytoplasmic disulfide bond pathway required for virion assembly.

Authors:  Christine L White; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 5.  Antibody-antigen complexes.

Authors:  D R Davies; E A Padlan; S Sheriff
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

6.  Vaccinia virus A21 virion membrane protein is required for cell entry and fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion.

Authors:  Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation.

Authors:  T G Senkevich; C L White; E V Koonin; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

9.  A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies.

Authors:  E J Wolffe; S Vijaya; B Moss
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

10.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04
View more
  9 in total

1.  The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains.

Authors:  Hua-Poo Su; Kavita Singh; Apostolos G Gittis; David N Garboczi
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

Review 2.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

3.  Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion.

Authors:  Karen Hayton; Deepak Gaur; Anna Liu; Jonathan Takahashi; Bruce Henschen; Subhash Singh; Lynn Lambert; Tetsuya Furuya; Rachel Bouttenot; Michelle Doll; Fatima Nawaz; Jianbing Mu; Lubin Jiang; Louis H Miller; Thomas E Wellems
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

4.  The Vaccinia Virus H3 Envelope Protein, a Major Target of Neutralizing Antibodies, Exhibits a Glycosyltransferase Fold and Binds UDP-Glucose.

Authors:  Kavita Singh; Apostolos G Gittis; Rossitza K Gitti; Stanley A Ostazeski; Hua-Poo Su; David N Garboczi
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

Review 5.  The molecular biology of frog virus 3 and other iridoviruses infecting cold-blooded vertebrates.

Authors:  V Gregory Chinchar; Kwang H Yu; James K Jancovich
Journal:  Viruses       Date:  2011-10-20       Impact factor: 5.048

6.  The 2.1 Å structure of protein F9 and its comparison to L1, two components of the conserved poxvirus entry-fusion complex.

Authors:  Ulrike S Diesterbeck; Apostolos G Gittis; David N Garboczi; Bernard Moss
Journal:  Sci Rep       Date:  2018-11-14       Impact factor: 4.379

7.  Localization of Frog Virus 3 Conserved Viral Proteins 88R, 91R, and 94L.

Authors:  Emily Penny; Craig R Brunetti
Journal:  Viruses       Date:  2019-03-19       Impact factor: 5.048

8.  Characterization of Eptesipoxvirus, a novel poxvirus from a microchiropteran bat.

Authors:  Shin-Lin Tu; Yoshinori Nakazawa; Jinxin Gao; Kimberly Wilkins; Nadia Gallardo-Romero; Yu Li; Ginny L Emerson; Darin S Carroll; Chris Upton
Journal:  Virus Genes       Date:  2017-07-06       Impact factor: 2.332

Review 9.  Viral enzymes.

Authors:  Jeroen R Mesters; Jinzhi Tan; Rolf Hilgenfeld
Journal:  Curr Opin Struct Biol       Date:  2006-11-07       Impact factor: 6.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.